{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-010190","form_type":"8-K","ticker":"IBO","cik":"0001834105","company_name":"IMPACT BIOMEDICAL INC.","filed_at":"2025-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.169068+00:00","generated_at":"2026-05-24T21:33:51.059831+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Impact Biomedical appoints Chan Heng Fai Ambrose to board of directors","bullets":["Appointed March 11, 2025, effective same date; over 45 years financial/equity investment experience.","Current director/chair roles include Alset International, DSS Inc., Hapi Metaverse, LiquidValue Development, Alset Inc., Sharing Services Global, HWH International, Value Exchange International.","No arrangement or understanding with any other person for appointment; no family relationships or related-party transactions per Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-010190","json":"https://secwatch.observer/filing/0001493152-25-010190.json","markdown":"https://secwatch.observer/filing/0001493152-25-010190.md","text":"https://secwatch.observer/filing/0001493152-25-010190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834105/000149315225010190/0001493152-25-010190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834105/000149315225010190/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T21:33:51.059831+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"960ae21526","claim":"Chan Heng Fai Ambrose was appointed as Director at IMPACT BIOMEDICAL INC..","evidence_excerpt":"On March 11, 2025, the Board of Directors of the Company appointed Mr. Chan Heng Fai Ambrose to serve as a Director of the Company, effective as of the same date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1834105/000149315225010190/0001493152-25-010190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}